Manuel Castellón Leal
Private Equity Investor bij Cross Road Biotech Inversiones Biotecnológicas SGEIC SA
Profiel
Mr. Manuel Castellón Leal is a Founding Partner & Legal Advisor at Cross Road Biotech Inversiones Biotecnológicas SGEIC SA. Mr. Castellón Leal also served on the board at Traslational Cancer Drugs Pharma SL.
He received his undergraduate degree from Universidad Complutense de Madrid and a graduate degree from the Instituto de Empresa SL.
Actieve functies van Manuel Castellón Leal
Bedrijven | Functie | Begin |
---|---|---|
Cross Road Biotech Inversiones Biotecnológicas SGEIC SA
Cross Road Biotech Inversiones Biotecnológicas SGEIC SA Investment ManagersFinance Cross Road Biotech Inversiones Biotecnologicas SGEIC SA (Cross Road Biotech Inversiones Biotecnologicas) is a venture capital firm founded in 2001 by Enrique Castellon Leal. The firm is headquartered in Madrid, Spain. | Private Equity Investor | 01-01-2001 |
Eerdere bekende functies van Manuel Castellón Leal
Bedrijven | Functie | Einde |
---|---|---|
Traslational Cancer Drugs Pharma SL
Traslational Cancer Drugs Pharma SL BiotechnologyHealth Technology Traslational Cancer Drugs Pharma SL engages in the discovery and development of therapeutic solutions for the treatment of cancer. Its TCD-717 choline kinase alpha inhibitor is an intravenously-administered small molecule designed to target cancer cells. It also provides technology in-licensing and out-licensing services. The company was founded by Juan Carlos San Juan on July 29, 2005 and is headquartered in Valladolid, Spain. | Directeur/Bestuurslid | - |
Opleiding van Manuel Castellón Leal
Universidad Complutense de Madrid | Undergraduate Degree |
Instituto de Empresa SL | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Bedrijven in privébezit | 2 |
---|---|
Cross Road Biotech Inversiones Biotecnológicas SGEIC SA
Cross Road Biotech Inversiones Biotecnológicas SGEIC SA Investment ManagersFinance Cross Road Biotech Inversiones Biotecnologicas SGEIC SA (Cross Road Biotech Inversiones Biotecnologicas) is a venture capital firm founded in 2001 by Enrique Castellon Leal. The firm is headquartered in Madrid, Spain. | Finance |
Traslational Cancer Drugs Pharma SL
Traslational Cancer Drugs Pharma SL BiotechnologyHealth Technology Traslational Cancer Drugs Pharma SL engages in the discovery and development of therapeutic solutions for the treatment of cancer. Its TCD-717 choline kinase alpha inhibitor is an intravenously-administered small molecule designed to target cancer cells. It also provides technology in-licensing and out-licensing services. The company was founded by Juan Carlos San Juan on July 29, 2005 and is headquartered in Valladolid, Spain. | Health Technology |